Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00922155
Other study ID # 96-0011B
Secondary ID
Status Completed
Phase N/A
First received June 15, 2009
Last updated June 15, 2009
Start date April 2007
Est. completion date March 2009

Study information

Verified date March 2007
Source Chang Gung Memorial Hospital
Contact n/a
Is FDA regulated No
Health authority Taiwan: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this study is to examine the usefulness of a balloon covered sheath as a guide sheath in endobronchial ultrasound guided transbronchial biopsy and bronchial brushing cytology for diagnosis of peripheral lung lesions


Description:

Flexible bronchoscopy has been applied in the diagnosis of peripheral pulmonary lesions (PPLs) for decades. Without accurate localization, the diagnostic yield for peripheral lung cancers by these procedures is limited and variable. Localization of peripheral lung cancers can be aided by the use of computed tomography or fluoroscopy during fiberoptic bronchoscopy. However, radiation exposure to staffs and patients is always a concern in these procedures.

The clinical application of endobronchial ultrasound (EBUS) included determination of the depth of tumor invasion in tracheobronchial wall, evaluation of tracheobronchial structure before therapeutic bronchoscopy, localization of site of biopsy, EBUS-guided transbronchial needle aspiration, and analysis of peripheral tumor. Under EBUS guidance, the diagnostic yield of transbronchial lung biopsy in patients with peripheral lung cancer by bronchoscopic examination was significantly improved without an increase in the complication rate. More recently, with the aid of a guide sheath (EBUS-GS), EBUS has been shown to increase the diagnostic yield of PPLs, even in patients with fluoroscopy-invisible lung nodules, and avert the need for surgical procedures.

Most recently used GS for EBUS are specified for the EBUS probe with an external diameter of 1.9 mm. Such a thin caliber GS is designed to reach the PPLs, sometimes with an aid of curette, to provide an exact site for repeated obtainment of adequate specimens. We wonder whether a larger caliber sheath transformed from a balloon covered with an external diameter of 2.6 mm without reaching the PPLs, can offer similar effectiveness in diagnosis of the PPLs. The results may provide an alternative way for EBUS-GS especially in those countries where the commonly used GS of EBUS is not available.


Recruitment information / eligibility

Status Completed
Enrollment 180
Est. completion date March 2009
Est. primary completion date March 2008
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- patients with peripheral pulmonary lesions who are going to receive bronchoscopy

Exclusion Criteria:

- endobronchial abnormalities

- associated lung parenchyma changes, ex. lung collapse or atelectasis

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Intervention

Device:
guide sheath
The guide sheath (GS) was originally the balloon covered sheath (MAJ-643R, external diameter 2.6mm) of the EBUS probe. The two ends of the balloon covered sheath were cut and trimmed. The EBUS probe was covered with guide sheath and then inserted through the working channel to the targeted bronchus.

Locations

Country Name City State
Taiwan Department or Chest Medicine, Chang Gung Memorial Hospital Taipei

Sponsors (2)

Lead Sponsor Collaborator
Chang Gung Memorial Hospital National Science Council, Taiwan

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary the diagnostic efficiency of flexible bronchoscopy(FB) in peripheral lung lesions(PPLs) 1 year Yes
Secondary complications, including bleeding, pneumothorax, respiratory failure, 1 year Yes
See also
  Status Clinical Trial Phase
Completed NCT01860898 - A Phase I Study of iPS Cell Generation From Patients With COPD N/A
Completed NCT05011890 - Remote Monitoring of Lung Cancer Patient-Reported Outcomes Using Moovcare® N/A
Completed NCT00290953 - Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide Phase 2/Phase 3
Completed NCT00132639 - Study of Preoperative Docetaxel or Cisplatin (CDDP) + Docetaxel for C-stage IB-II Non-Small Cell Lung Cancer (NSCLC) Phase 2
Terminated NCT00241267 - Bronchial Ultrasonography Via a Fibrescope: Pilot Study in Tumoral Disease N/A
Terminated NCT02673021 - MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s) N/A
Terminated NCT00232128 - Protocol for Radiofrequency Ablation of Pulmonary Neoplasms N/A
Completed NCT00042679 - A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer. Phase 2
Not yet recruiting NCT05857995 - Precision Lung Cancer Survivorship Care Intervention N/A
Recruiting NCT04699188 - Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation Phase 1/Phase 2
Completed NCT02410603 - Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer
Recruiting NCT02549638 - Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma
Completed NCT02483052 - RejuvenAir Lobectomy for Safety and Histology Phase 1/Phase 2
Completed NCT02370303 - A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System
Completed NCT01470248 - Study of Arsenic Trioxide in Small Cell Lung Cancer Phase 2